Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Suzetrigine for Acute Pain Control in Patients With Multiple Rib Fractures
NCT07145346Phase 4Enrolling by invitation
- Sponsor
- University of California, Irvine
- Start
- Nov 2025
- Primary completion
- Aug 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of suzetrigine in acute pain, rib fracture, sponsored by University of California, Irvine. Started Nov 2025; status: enrolling by invitation.
02
Drugs
suzetrigine
03
Conditions
acute painrib fracture
Beyond the preview
Go deeper on NCT07145346.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07145346.